[7 February 2007]Ann Arbor, MI-based Aastrom Biosciences Inc./span> reported 2007 2nd-quarter results. For the three months ended 31 December 2006, Aastrom had revenues of
$158,000.revenue: $158,000 total costs and expenses: $4,898,000 research and development expenses: $2,563,000 net loss: $4,225,000, or $.04 per share cash: $36,300,000
For the six months ended 31 December 2006, Aastrom's net loss was
$0.07 per share.
More... Aastrom Biosciences Inc. in a Nutshell
The following was copied from Aastrom.com."Aastrom is developing autologous stem cell products for use in regenerative medicine. Aastrom's platform manufacturing technology enables the production of patient-specific cell products with multiple tissue regenerative capabilities from a small sample of the patient's bone marrow."
Creator: Gerald D. Thurman
Created: 07 February 2007